Sign inJoin waitlistJoin the waitlist

Elijah Stommel

Professor of Neurology · Geisel School of Medicine

Credentials: · · · · · ·

History

Geisel School of Medicine
Present

Neurology
1988–1991
Dartmouth Hitchcock Medical Center
1984–1991
St. Elizabeth's Medical Center
1987–1988
Boston University School of Medicine
1983–1987
Boston University School of Medicine
1984
Bowdoin College, BA 1977
1979–1983

Research

Varicella-zoster virus myelitis: an expanding spectrum
Case report · Neurology · 1994 · 135 citations
A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms
Amyotrophic Lateral Sclerosis · 2009 · Last of 9 authors · 120 citations
The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis
Review · Toxins · 2010 · Last of 3 authors · 79 citations

Walter Bradley
18 papers
TC
Tracie Caller
16 papers · 11 as a resident
EP
Erik Pioro
8 papers
Brent Harris
7 papers
Nicholas Field
7 papers · 1 as a resident
Courtney McIlduff
4 papers
Jeffrey Cohen
4 papers
RT
Rup Tandan
4 papers
Adam Quick
3 papers
DF
Dominic Facciponte
3 papers
Glen Greenough
3 papers
JS
Joseph Schwartzman
3 papers

Grants

RFA-TS-24-010: Persistent Environmental Toxicants in Veteran CNS Tissue: Identifying Exposures Determining Higher ALS Risk
ATSDR · R01
Contact PI · $1M · Dartmouth-Hitchcock Clinic
2024–2027
Investigating Toxic Elements and Nanoparticles in ALS Etiology: A Geospatial and Toxicological Evaluation of Massachusetts ALS Registry Patients
National Institute of Environmental Health Sciences · R01
Contact PI · $2.1M · Dartmouth-Hitchcock Clinic
2022–2027
Identify, Analyze, and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) - 2018
ATSDR · R01
Contact PI · $1.5M · Dartmouth-Hitchcock Clinic
2018–2021
Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (Als)
ATSDR · R01
Contact PI · $55.8K · Dartmouth-Hitchcock Clinic
2018–2019

Clinical trials

Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
Principal investigator · Terminated · Phase 2
Elijah W. Stommel
2018–2022
Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
Principal investigator · Terminated · Phase 2
Dartmouth-Hitchcock Medical Center
2008–2011
Phase II Study Using Thalidomide for the Treatment of ALS
Principal investigator · Completed · Phase 2
Dartmouth-Hitchcock Medical Center
2005–2007
EIM Via the Myolex mScan as an ALS Biomarker
Site PI · Recruiting
Beth Israel Deaconess Medical Center
2025–2027